Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer.

MLA

Borneman, Rebecca M., et al. “Phosphodiesterase 10A (PDE10A) as a Novel Target to Suppress β-Catenin and RAS Signaling in Epithelial Ovarian Cancer.” Journal of Ovarian Research, vol. 15, no. 1, Nov. 2022, p. 120. EBSCOhost, https://doi.org/10.1186/s13048-022-01050-9.

APA

Borneman, R. M., Gavin, E., Musiyenko, A., Richter, W., Lee, K. J., Crossman, D. K., Andrews, J. F., Wilhite, A. M., McClellan, S., Aragon, I., Ward, A. B., Chen, X., Keeton, A. B., Berry, K., Piazza, G. A., Scalici, J. M., & da Silva, L. M. (2022). Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer. Journal of Ovarian Research, 15(1), 120. https://doi.org/10.1186/s13048-022-01050-9

Chicago

Borneman, Rebecca M, Elaine Gavin, Alla Musiyenko, Wito Richter, Kevin J Lee, David K Crossman, Joel F Andrews, et al. 2022. “Phosphodiesterase 10A (PDE10A) as a Novel Target to Suppress β-Catenin and RAS Signaling in Epithelial Ovarian Cancer.” Journal of Ovarian Research 15 (1): 120. doi:10.1186/s13048-022-01050-9.